Utama › Karsinoma Sel Skuamosa Kepala dan Leher › Virginia › Arlington
Kajian klinikal Karsinoma Sel Skuamosa Kepala dan Leher di Arlington, VA
26 kajian untuk Karsinoma Sel Skuamosa Kepala dan Leher sedang mencari peserta di lokasi dalam dan sekitar Arlington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Mengambil pesertaFasa 1
- ALX Center 2, Fairfax · 11 mi jauh
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Mengambil pesertaFasa 1
- Site 04, Fairfax · 11 mi jauh
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Mengambil pesertaFasa 2
- Inova Fairfax Hospital, Falls Church · 4 mi jauh
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauh
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Mengambil pesertaFasa 3
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Mengambil pesertaFasa 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Mengambil pesertaFasa 1/2
- NEXT Oncology, Fairfax · 11 mi jauh
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Mengambil pesertaFasa 2
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Research Site, Fairfax · 11 mi jauh
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Mengambil pesertaFasa 1
- Normunity Investigational Site, Fairfax · 11 mi jauh
A Study of DM005 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi jauh
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT, Fairfax · 11 mi jauh
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Mengambil pesertaFasa 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mi jauh
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Mengambil pesertaFasa 1
- NEXT Texas LLC - Virginia, Fairfax · 11 mi jauh
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Mengambil pesertaFasa 1
- Dren Investigational Site, Fairfax · 11 mi jauh
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Mengambil pesertaFasa 1
- NEXT Oncology, Fairfax · 11 mi jauh
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Research Site 102, Fairfax · 11 mi jauh
- Research Site 112, Fairfax · 11 mi jauh
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Kajian Karsinoma Sel Skuamosa Kepala dan Leher di bandar lain
- Houston, TX47 kajian
- Los Angeles, CA42 kajian
- Boston, MA40 kajian
- Nashville, TN39 kajian
- New York City, NY39 kajian
- St. Louis, MO28 kajian
- Chicago, IL26 kajian
- Philadelphia, PA26 kajian
- Atlanta, GA24 kajian
- Pittsburgh, PA22 kajian
- New Haven, CT22 kajian
- San Antonio, TX22 kajian
Kajian lain di Arlington
- Kanser Paru-paru Bukan Sel Kecil104 kajian
- Kanser Metastatik53 kajian
- Kanser Kolorektal52 kajian
- Kanser (semua jenis)48 kajian
- Kanser Payudara46 kajian
- Kanser Ovari46 kajian
- Kanser Paru-paru41 kajian
- Kanser Endometrium39 kajian
- Kanser Pankreas33 kajian
- Kanser Paru-paru Sel Kecil23 kajian
- Kanser Payudara Triple-Negatif20 kajian
- Kanser Perut20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.